These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32005975)

  • 1. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
    Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
    J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells.
    Bao X; Yu H; Chen Z; Chen W; Xiao Y; Wu X; Li Z
    Biochem Biophys Res Commun; 2024 Nov; 734():150641. PubMed ID: 39243676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
    Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
    Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
    Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
    Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
    Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
    BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
    Liu DP; Wang Y; Koeffler HP; Xie D
    Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
    Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
    Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
    Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
    Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
    Yuan W; Chen Z; Chen Z; Wu S; Guo J; Ge J; Yang P; Huang J
    Neoplasma; 2012; 59(1):105-13. PubMed ID: 22103904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction.
    Goichberg P; Bai Y; D'Amario D; Ferreira-Martins J; Fiorini C; Zheng H; Signore S; del Monte F; Ottolenghi S; D'Alessandro DA; Michler RE; Hosoda T; Anversa P; Kajstura J; Rota M; Leri A
    Circ Res; 2011 Apr; 108(9):1071-83. PubMed ID: 21415392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
    Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
    Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
    Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
    Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.
    Hong HN; Won YJ; Shim JH; Kim HJ; Han SH; Kim BS; Kim HS
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1649-1663. PubMed ID: 29948146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients.
    Yuan WJ; Ge J; Chen ZK; Wu SB; Shen H; Yang P; Hu B; Zhang GW; Chen ZH
    Dig Dis Sci; 2009 Nov; 54(11):2410-7. PubMed ID: 19101799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.